MedTrace Logo

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

NCT07255001 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-28

No results posted yet for this study

Summary

The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are:

* Is it feasible to measure hand grip strength as part of a clinic visit?
* Are changes in hand grip strength related to changes in body composition?
* Is hand grip strength related to a person's well-being?
* Is hand grip strength related to how a tumour responds to treatment?

Participants will squeeze a device with their hand to measure their hand grip strength and complete questionnaires about their well-being when they are seen in clinic for their regular medical care for PDAC.

Conditions

  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Hand Grip Strength

Interventions

DEVICE

Hand grip strength assessments using a dynamometer

Squeeze a dynamometer with one hand to measure hand grip strength.

Sponsors & Collaborators

  • British Columbia Cancer Agency

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07255001 on ClinicalTrials.gov